Recall: Brimonidine

Mar. 2023Pharmacy Updates

Apotex Corp. is voluntarily recalling six lots of Brimonidine Tartrate Ophthalmic Solution, 0.15%. The drug is used to reduce elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. This recall is due to cracks that have developed in some of the Brimonidine tartrate ophthalmic solution bottles’ caps. Read the full text of the Brimonidine recall.

Recent Announcements

Voluntary nationwide recall: Famotidine (Fresenius – November)

Fresenius Kabi USA, LLC is recalling three lots (6133156, 6133194, and 6133388) of Famotidine Injection, USP, 20 mg per 2 mL. Famotidine is used to treat excessive secretion of stomach acid or stomach ulcers.

Nov. 2025Pharmacy Updates

Medicaid provider update: High-cost Medicaid drug billing

Billing requirements for Medicaid-covered drugs

Nov. 2025Important Notices

Training Webinar: Conversio Health COPD Management Program

Please join us for a live training webinar for primary care providers and pulmonologists by UPMC Health Plan that will provide an overview of a comprehensive COPD management program from Conversio Health.

Nov. 2025Education/Webinars